Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity

This publication has 44 references indexed in Scilit:

• Taxane-containing chemotherapy in the treatment of early breast cancer patients
  Annals of Oncology, 2006
• Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF‐7 breast cancer cells
  FEBS Letters, 2006
• Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: An in vivo study
  Molecular and Cellular Endocrinology, 2005
• The transcriptional targets of p53 in apoptosis control
  Biochemical and Biophysical Research Communications, 2005
• Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling
  Oncogene, 2004
• Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells
  Oncogene, 2003
• Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells
  Anti-Cancer Drugs, 2003
• Caveolin-1 Phosphorylation in Human Squamous and Epidermoid Carcinoma Cells: Dependence on ErbB1 Expression and Src Activation
  Experimental Cell Research, 2002
• The Mode of Action of Taxol: Apoptosis at Low Concentration and Necrosis at High Concentration
  Biochemical and Biophysical Research Communications, 1999
• Early effects of PP60v-src kinase activation on caveolae
  Journal of Cellular Biochemistry, 1998